Clinical Trial Results: A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight [Phase 2]

View source ↗

Summary

Phase 2b trial results for MET097 in adults with obesity or overweight have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MET097

Snippet

Sponsor: Pfizer | Conditions: Obesity, Overweight or Obesity | Phase 2 | Status: COMPLETED | Results posted: 2026-08-28